Skip to content

Effect of bupivacaine liposomes on postoperative analgesia in patients undergoing thoracoscopic surgery

Effect of bupivacaine liposomes on postoperative analgesia in patients undergoing thoracoscopic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079471
Enrollment
Unknown
Registered
2024-01-04
Start date
2024-01-05
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung space-occupying

Interventions

Anterior serratus plane block group(Trial group):Bupivacaine liposomal anterior serration plane block
Incision infiltration group(Control group):Bupivacaine liposome incision infiltration

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age =18 years, =75 years, gender is not limited (2) The surgical procedure was a single-port thoracoscopic partial lung resection (3) The duration of the operation will not exceed 4 hours (4) BMI: 18-28kg/m2 (5) ASA classification I-III (6) Obtain informed consent from the patient and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Contraindications to nerve block: infection at the puncture site, allergy to local anesthetics, coagulation disorders (2) Liver and kidney failure (3) Preoperative use of analgesic drugs (4) A history of chronic pain or opioid abuse (5) Mental illness (6) Pregnant and lactating women (7) Patients who refuse to participate (8) Others who are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) scores;

Secondary

MeasureTime frame
Numerical Rating Score;sufentanil dosage;Number of PCA self-controls and total amount of medication administered;Remedial analgesic medication duration and dosage;

Countries

China

Contacts

Public ContactYanhua Chen

The First Affiliated Hospital of Guangxi Medical University

402009694@qq.com+86 139 7885 8025

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026